|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.174 EUR | +2.10% |
|
+3.76% | -38.99% |
| 07-24 | Adocia provides a second-quarter update, Stifel still rates it a buy |  |
| 07-23 | Adocia SA Reports Unaudited Revenue Results for Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 92.39M | - | ||||
| 70.85B | |||||
| 55.41B | |||||
| 29.43B | - | ||||
| 24.12B | |||||
| 23.31B | - |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
